Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
BEDFORD, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early...
Day: February 28, 2023
Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting
Continues to Raise Awareness of the LIBERTY® Robotic System Ahead of Commercialization PlansHINGHAM, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) --...
Parexel Introduces Expert Series – New Medicines, Novel Insights
New evidence-based reports offer timely analysis and actionable guidance to drug developers bringing critical new therapies to marketDURHAM, N.C., Feb. 28,...
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging
Swoop® Portable MR Imaging® system positioned to offer even greater clinical utility in neurocritical careGUILFORD, Conn., Feb. 28, 2023 (GLOBE...
AIM ImmunoTech Announces Phase 2 Study of Ampligen® for the Treatment of Pancreatic Cancer is Open and Recruiting Patients
Ongoing efforts to open additional clinical sites for recruitment at premier cancer centers across the U.S. and Europe are in...
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
ABVC BioPharma Provides 2023 Pipeline Update
FREMONT, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
Research illustrates company’s progress in working to end the diagnostic odyssey and includes data with implications for how care is...
Longeveron Appoints Wa’el Hashad as Chief Executive Officer
Hashad is a former executive at Avanir, Amgen, Boehringer Ingelheim, Eli Lilly, and early-stage biotechnology companies Global leader brings over...
Assure Holdings to Present at the Gravitas 6th Annual Growth Conference
DENVER, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative...
ContraFect Announces Pricing of $10.0 Million Registered Direct Offering and Concurrent Private Placement
YONKERS, N.Y., Feb. 28, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery...
Coherus BioSciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that its fourth...